PLK1 and chronic obstructive pulmonary disease: CASP3, involved in the regulation of airway smooth muscle cell apoptosis through the Polo-like Kinase 1 - Caspase-3 (PLK1-CASP3) pathway, is another vital target for COPD treatment (39).